Click on the image to check the artwork
By certification 
Composition:
Lanzidime® 250 mg IV/IM Injection: White to faintly yellow powder in vials containing 250 mg of Ceftazidime (as pentahydrate), with sodium carbonate.
Lanzidime® 500 mg IV/IM Injection: White to faintly yellow powder in vials containing 500 mg of Ceftazidime (as pentahydrate), with sodium carbonate.
Lanzidime® 1 g IV/IM Injection: White to faintly yellow powder in vials containing 1 g of Ceftazidime (as pentahydrate), with sodium carbonate.
Lanzidime® 250 mg IV/IM Injection: White to faintly yellow powder in vials containing 250 mg of Ceftazidime (as pentahydrate), with sodium carbonate.
Lanzidime® 500 mg IV/IM Injection: White to faintly yellow powder in vials containing 500 mg of Ceftazidime (as pentahydrate), with sodium carbonate.
Lanzidime® 1 g IV/IM Injection: White to faintly yellow powder in vials containing 1 g of Ceftazidime (as pentahydrate), with sodium carbonate.